DAVID PETER SACHS
Medical Practice in Palo Alto, CA
License number
Pennsylvania MD052699L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Palo Alto, CA 94306
Pennsylvania
Pennsylvania
Personal information
See more information about DAVID PETER SACHS at radaris.comName
Address
Phone
5383 Cox Dr, Valley Springs, CA 95252
5119 Rosbury Dell Pl, Sacramento, CA 95843
5 Valley Cir, Mill Valley, CA 94941
41303 Pine Tree Cir, Temecula, CA 92591
3618 Laguna Ave, Palo Alto, CA 94306
Professional information
Dr. David P Sachs - MD (Doctor of Medicine)
Specialties:
Pulmonology
Languages:
English
Hospitals:
Pulmonary Diagnostic and Rehabilitation
145 N California Ave, Palo Alto 94301
300 Pasteur Dr, Stanford 94305
Sequoia Hospital
170 Alameda De Las Pulgas, Redwood City 94062
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Pulmonary Diagnostic and Rehabilitation
145 N California Ave, Palo Alto 94301
300 Pasteur Dr, Stanford 94305
Sequoia Hospital
170 Alameda De Las Pulgas, Redwood City 94062
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
145 N California Ave, Palo Alto 94301
300 Pasteur Dr, Stanford 94305
Sequoia Hospital
170 Alameda De Las Pulgas, Redwood City 94062
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Pulmonary Diagnostic and Rehabilitation
145 N California Ave, Palo Alto 94301
300 Pasteur Dr, Stanford 94305
Sequoia Hospital
170 Alameda De Las Pulgas, Redwood City 94062
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1972
University Hospital Of Cleveland
Stanford University School Of Medicine
Graduated: 1972
University Hospital Of Cleveland
Methods For Nicotine Replacement Dosage Determination
US Patent:
2004000, Jan 8, 2004
Filed:
Jun 19, 2003
Appl. No.:
10/600805
Inventors:
David Sachs - Palo Alto CA, US
International Classification:
A61K031/454
US Classification:
514/343000
Abstract:
A method for predicting nicotine replacement dosage to achieve a target nicotine serum concentration relies on measuring blood nicotine concentration prior to smoking cessation. At least two values corresponding to other patient characteristics, such as body mass, cumulative smoking, psychological dependence, age, and menopausal status, are also determined and used to predict expected blood nicotine concentrations based on nicotine replacement dosages. Such methods are useful in achieving target blood nicotine concentrations for smoking cessation and therapy.